China Medical University (CMU) and Healthcare System showcased groundbreaking advancements in AI-driven drug discovery and cancer therapy at the 8th Healthcare Expo Taiwan, reinforcing their position as a global leader in biomedical innovation. This milestone highlights Taiwan’s growing influence in healthcare technology and its commitment to transforming patient care through cutting-edge research and international collaboration.

Dr. Chang-Hai Tsai, Chairman of CMU and Healthcare System, emphasized the institution’s dedication to cutting-edge research and strategic global partnerships. Through collaboration with Kyoto University, CMU has established a Global Research Center to drive progress in cancer research, regenerative medicine, and AI-powered drug discovery, setting new industry benchmarks.

Breakthrough in Cancer Therapy: 90% Tumor Reduction with Allogeneic CAR-T

CMU and Healthcare System, in partnership with Ever Supreme Bio Technology, unveiled the world’s first allogeneic CAR-T therapy for solid cancers. This innovative therapy has demonstrated over 90% tumor reduction in pre-clinical studies, marking a significant leap forward in solid tumor treatment. Human clinical trials are currently underway, with FDA approval paving the way for a transformative approach to cancer care.

Precision Medicine Innovations: AI and Exosome Technology

Shine-On Biomedical and Shine Out Bio Technology introduced cutting-edge precision medicine platforms, including:

• SOA101 Trispecific Antibody – A nanobody-based therapy integrating two immune checkpoint inhibitors, now progressing through FDA-reviewed Phase I/IIa clinical trials for cancer treatment.
• SOB100 HLA-G Targeted Exosome – A breakthrough drug delivery system that enhances tumor-targeted precision therapy while minimizing side effects. Clinical trials are set to begin in 2025.

AI-Powered Healthcare Solutions

CMU and Healthcare System presented next-generation AI-driven medical solutions, revolutionizing healthcare efficiency and clinical decision-making:

• Child Growth Assessment System – AI-powered diagnostics for personalized treatment planning.
• HiThings Tele-ICU – Real-time 3D modeling enhances critical care management.
• Smart Health Scheduling – AI optimizes health examination workflows.
• AI-Assisted Brain Imaging for Central Nervous System Disorders – Enhancing diagnosis with advanced visual scale analysis.
• MIRA: AI-Powered Medical Record Assistant – Improving accuracy and efficiency in medical documentation.

Advancing Specialized Healthcare Innovations

CMUH continues to lead in cutting-edge therapies, introducing:

• MRgFUS for Parkinson’s Disease – A non-invasive MRI-guided therapy offering new hope to patients.
• Proton Therapy Center – Precision-targeted cancer treatments with reduced side effects.
• Genetic Testing for Gout Risk Prediction – A personalized medicine approach for effective management.

Global Collaboration with Kyoto University

The launch of the CMU-Kyoto University Global Research Center strengthens ties in cancer research, translational medicine, and regenerative therapies. This initiative, supported by CMU Research Park, integrates academic and industrial expertise, driving cutting-edge developments from research to clinical application.

Shaping the Future of Medicine

Dr. Der-Yang Cho, Superintendent of CMUH, highlighted AI’s transformative impact on drug discovery and clinical applications, reinforcing CMU and Healthcare System’s commitment to bridging AI, biotechnology, and clinical practice.

CMU and Healthcare System’s pioneering contributions at Healthcare Expo Taiwan cement Taiwan’s growing leadership in global healthcare innovation. Through international collaboration and groundbreaking research, the institution continues to drive the future of medicine forward.